drugset
drugset / Trial / NCT02946996

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

NCT02946996 ↗

Phase 2 Terminated 41 enrolled Medical University of South Carolina
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to look at the effect that the study drug OPC has on AGE levels in patients with prostate cancer.

Timeline

Start
2016-12-28
Primary completion
2023-12-05
Completion
2024-08-19

Outcome

Outcome not reported

Stopped (Enrollment): “Investigator retired from clinical practice prior to enrollment goal being met.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg —

Indications

prostate cancer